Stay updated on Subcutaneous Nivolumab + rHuPH20 Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous Nivolumab + rHuPH20 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous Nivolumab + rHuPH20 Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page’s footer revision label changes from v3.8.0 to v3.8.1.
    Difference
    0.0%
    Check dated 2026-11-18T16:21:25.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page now displays the study record for subcutaneous nivolumab, including study design and outcome measures, participant eligibility, locations, and supporting documents.
    Difference
    86%
    Check dated 2026-11-11T17:36:35.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changed from v3.7.2 to v3.8.0, while the study record page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-28T15:47:59.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    A sitewide notice announces an NIH website transition and says both “Super Intelligence” and “Artificial Intelligence” may appear during the change.
    Difference
    1%
    Check dated 2026-10-21T21:53:48.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer revision number changed from v3.7.1 to v3.7.2; the study record remains unavailable behind a 403 error.
    Difference
    0.2%
    Check dated 2026-10-14T22:06:45.000Z thumbnail image
  7. Check
    42 days ago
    Change Detected
    Summary
    The footer’s site revision indicator changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T22:11:50.000Z thumbnail image

Stay in the know with updates to Subcutaneous Nivolumab + rHuPH20 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous Nivolumab + rHuPH20 Clinical Trial page.